This brand name is authorized in Nigeria.
The drug PARAMARK contains one active pharmaceutical ingredient (API):
1
|
UNII
362O9ITL9D - ACETAMINOPHEN
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
B4-4012 | Solution for infusion | Paramark Infusion INJ_SOL 10 mg/mL | Solution for Infusion Each mL contains: Paracetamol 10 mg (1000 mg/100 mL) Excipients: Water for Injection, Mannitol, Disodium Hydrogen Phosphate, Sodium Hydroxide, Hydrochloric Acid | 26/08/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
N02BE01 | Paracetamol | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | B4-4012 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.